Merck Argues Investors Can’t Sue over Vioxx Drug

Merck and Co., the makers of Vioxx argued in court this week that investors can’t sue them for the defunct product because the statute of limitation is over for a defective drug lawsuit.  Vioxx, which was pulled off the market because it doubled the risks of heart attack, stroke and death cost the company and [...]

Share

Measures to Stop Accidental Overdose Considered by FDA

In an effort to curb a rise in accidental overdoses, the FDA is working with physicians to identify high risks medicines that pose the greatest risks. The hope is that the measure will prevent the 4 million emergency room visits each year prompted by drug misuses or larger than recommended doses of pharmaceuticals. These visits [...]

Share

Heart Problems Possibly Sparked by Prostate Cancer Treatment

A common hormone treatment for men with prostate cancer may be linked to a slight increase in heart related  health issues.   European medical experts learned through intensive studies that prostate cancer patients had a 28 percent higher risk of having a fatal heart attack as well as 21 percent chance of dying from heart disease [...]

Share